Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Nanomaterials (Basel) ; 11(10)2021 Sep 22.
Artículo en Inglés | MEDLINE | ID: mdl-34684906

RESUMEN

We have previously demonstrated that iron oxide nanoparticles with dopamine-anchored heterobifunctional polyethylene oxide (PEO) polymer, namely PEO-IONPs, and bio-functionalized with sialic-acid specific glycoconjugate moiety (Neu5Ac(α2-3)Gal(ß1-4)-Glcß-sp), namely GM3-IONPs, can be effectively used as antibacterial agents against target Escherichia coli. In this study, we evaluated the biocompatibility of PEO-IONPs and GM3-IONPs in a normal human colon cell line CCD-18Co via measuring cell proliferation, membrane integrity, and intracellular adenosine triphosphate (ATP), glutathione GSH, dihydrorhodamine (DHR) 123, and caspase 3/7 levels. PEO-IONPs caused a significant decrease in cell viability at concentrations above 100 µg/mL whereas GM3-IONPs did not cause a significant decrease in cell viability even at the highest dose of 500 µg/mL. The ATP synthase activity of CCD-18Co was significantly diminished in the presence of PEO-IONPs but not GM3-IONPs. PEO-IONPs also compromised the membrane integrity of CCD-18Co. In contrast, cells exposed to GM3-IONPs showed significantly different cell morphology, but with no apparent membrane damage. The interaction of PEO-IONPs or GM3-IONPs with CCD-18Co resulted in a substantial decrease in the intracellular GSH levels in a time- and concentration-dependent manner. Conversely, levels of DHR-123 increased with IONP concentrations. Levels of caspase 3/7 proteins were found to be significantly elevated in cells exposed to PEO-IONPs. Based on the results, we assume GM3-IONPs to be biocompatible with CCD-18Co and could be further evaluated for selective killing of pathogens in vivo.

2.
Inorg Chem ; 59(21): 15707-15716, 2020 Nov 02.
Artículo en Inglés | MEDLINE | ID: mdl-33078925

RESUMEN

Randomly oriented vanadium dioxide (VO2) nanowires were produced on a glass substrate by spin coating from a cosolvent. SEM studies reveal that highly dense VO2 nanowires were grown at an annealing temperature of 400 °C. X-ray diffraction (XRD) provides evidence of the high crystallinity of the VO2 nanowires-embedded VO2 thin films on the glass substrate at 400 °C. Characterization by high-resolution transmission electron microscopy (HR-TEM) confirmed the formation of VO2 nanowires. The optical band gap of the nanowires-embedded VO2 thin films was also calculated from the transmittance data to be 2.65-2.70 eV. The growth mechanism of the solution-processed semiconducting VO2 nanowires was proposed based on both solvent selection and annealing temperature. Finally, the solar water splitting ability of the VO2 nanowires-embedded VO2 thin films was demonstrated in a photoelectrochemical cell (PEC).

3.
Nanomedicine ; 14(4): 1191-1200, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29526511

RESUMEN

Restenosis by neointimal hyperplasia is still an ongoing concern in endovascular surgery. Slowing vascular smooth muscle cell (VSMC) proliferation by reversing the phenotype change, would allow vessel healing and re-endotheliazation. To accomplish this, we have developed heparin-coated magnetic nanoparticles for targeted drug therapy of neointimal hyperplasia. Iron oxide nanoparticles were modified with a poly (ethylene oxide) based coating and then further functionalized with heparin. In vitro experiments were conducted to observe changes in phenotype, metabolic activity, and viability of three relevant cell lines including VSMC, endothelial cells and fibroblasts. Inhibition of proliferation of VSMCs was observed with doses as low as 1 µg/mL Fe of heparin loaded nanoparticle where endothelial cells showed an increase in proliferation in response to treatment. Fibroblasts showed relatively low response. Results suggest proliferation suppression of VSMCs due to phenotype coupled with the increase in endothelial cell proliferation at low doses of heparin coated nanoparticles.


Asunto(s)
Heparina/química , Heparina/uso terapéutico , Hiperplasia/tratamiento farmacológico , Nanopartículas de Magnetita/química , Nanopartículas de Magnetita/uso terapéutico , Neointima/tratamiento farmacológico , Animales , Línea Celular , Proliferación Celular/efectos de los fármacos , Células Endoteliales/efectos de los fármacos , Femenino , Ratones , Ratones Desnudos , Ratas , Porcinos
4.
Nanotoxicology ; 8(5): 477-84, 2014 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-23586422

RESUMEN

Nanoparticles (NPs) have been shown to induce dispersal events in microbial biofilms but the mechanism of the dispersal is unknown. Biofilms contaminate many man-made aquatic systems such as cooling towers, spas and dental lines. Within these biofilms, Legionella pneumophila is a primary pathogen, leading to these environments serving as sources for disease outbreaks. Here we show a reduction in biofilm bio-volume upon treatment with citrate-coated 6-nm platinum NPs, polyethylene glycol (PEG)-coated 11-nm gold NPs, and PEG-coated 8-nm iron oxide NPs. Treatment with citrate-coated 8-nm silver NPs, however, did not reduce biomass. The synthesis of NPs that remain dispersed and resist irreversible aggregation in the exposure media appears to be a key factor in the ability of NPs to induce biofilm dispersal.


Asunto(s)
Antibacterianos/farmacología , Biopelículas/efectos de los fármacos , Legionella pneumophila/efectos de los fármacos , Nanopartículas del Metal/química , Análisis de Varianza , Antibacterianos/química , Recuento de Colonia Microbiana , Oro/química , Oro/farmacología , Nanopartículas de Magnetita/química
5.
Ther Deliv ; 2(6): 815-38, 2011 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-22822511

RESUMEN

Many nanotechnologies, which enable unique approaches to treat cancer, have been developed based upon non-toxic organic and inorganic materials to improve current cancer treatments. The use of inorganic materials to form magnetic nanoparticles for hyperthermia therapy is of great interest for localized treatment of cancers without effecting adjacent healthy tissue. Extensive clinical trials have begun using magnetic hyperthermia in animal models. The purpose of this article is to address different factors that affect targeting, heating and biodistribution to safely control the therapeutic efficacy of targeted magnetic hyperthermia. This method involves accumulation of magnetic nanoparticles at a tumor site and then manipulating the magnetic properties of the nanoparticles to heat the targeted tissues.


Asunto(s)
Sistemas de Liberación de Medicamentos/métodos , Hipertermia Inducida/métodos , Campos Magnéticos , Nanopartículas del Metal/uso terapéutico , Disponibilidad Biológica , Fenómenos Químicos , Humanos , Nanopartículas del Metal/efectos adversos , Nanopartículas del Metal/química , Neoplasias/terapia
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...